What is the appropriate management of a patient presenting with melena?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Melena

Patients presenting with melena require immediate upper endoscopy (esophagogastroduodenoscopy) within 24 hours after hemodynamic stabilization, as melena indicates upper gastrointestinal bleeding in the vast majority of cases. 1, 2

Immediate Assessment and Resuscitation

Hemodynamic Evaluation

  • Calculate the shock index immediately (heart rate ÷ systolic blood pressure); a value >1 indicates hemodynamic instability requiring ICU admission and aggressive intervention 2, 3
  • Check for shock defined as pulse >100 beats/min AND systolic blood pressure <100 mmHg 1
  • Assess for orthostatic hypotension (drop in BP >20 mmHg or HR increase >20 bpm when standing), which indicates significant blood loss requiring ICU admission 2
  • Perform digital rectal examination to confirm the presence of melena (black, tarry, sticky stool with distinctive odor) and exclude anorectal pathology 1, 2

Immediate Resuscitation (for Unstable Patients)

  • Initiate IV fluid resuscitation immediately with two large-bore catheters and aggressive crystalloid infusion (normal saline or Ringer's lactate) to normalize blood pressure and heart rate before endoscopic evaluation 1, 2
  • Apply a restrictive transfusion strategy: maintain hemoglobin >7 g/dL for patients without cardiovascular disease 1, 2
  • For patients with cardiovascular disease, massive bleeding, or significant comorbidities, maintain hemoglobin >8-9 g/dL 1, 2
  • Correct coagulopathy immediately: transfuse fresh frozen plasma if INR >1.5 and platelets if platelet count <50,000/µL 2, 3

Risk Stratification

Rockall Score Components (Prognostic)

The following factors independently predict mortality and should be documented 1:

  • Age: mortality is rare under age 40, but reaches 30% in patients >90 years 1
  • Comorbidity: deaths are almost entirely restricted to patients with significant medical diseases (advanced renal/liver disease, disseminated cancer, cardiac/respiratory/CNS disease) 1
  • Shock: defined as pulse >100 beats/min AND systolic BP <100 mmHg 1
  • Endoscopic findings: active bleeding from a peptic ulcer in a shocked patient carries an 80% risk of continuing bleeding or death; a non-bleeding visible vessel carries 50% rebleeding risk 1

Diagnostic Approach

Primary Diagnostic Test

  • Upper endoscopy (EGD) should be performed within 24 hours as the first-line diagnostic procedure for melena, as it indicates an upper GI source in the vast majority of cases 1, 2
  • The majority of patients can be safely endoscoped on an early elective list (ideally the morning after admission) 1, 2
  • A minority of cases need emergency "out of hours" endoscopy, which must be available 24 hours a day, seven days a week 1, 2
  • Endoscopy is best undertaken in a fully equipped endoscopy unit staffed by nurses trained in the care of ill patients; for unstable patients requiring out-of-hours endoscopy, an operating theatre environment with anesthetic cover may be safer 1

For Hemodynamically Unstable Patients (Shock Index >1)

  • If the patient remains severely unstable despite resuscitation, CT angiography may be considered to rapidly localize bleeding before therapeutic intervention 1, 2
  • However, upper endoscopy remains the definitive diagnostic and therapeutic modality for melena 1, 2

Therapeutic Management

Endoscopic Treatment Options

  • Widely available endoscopic therapies include: injection therapy, mechanical therapy (endoscopic clip placement), ablative therapy (argon plasma coagulation or other laser therapy), or a combination of modalities 1
  • The efficacy of endoscopic treatment is not well-studied in gastric cancer patients, but limited data suggest that while initially effective, the rate of recurrent bleeding is very high 1

Alternative Interventions

  • Interventional radiology with angiographic embolization may be useful when endoscopy is not helpful 1
  • External beam radiation therapy (EBRT) has been shown to effectively manage acute and chronic gastrointestinal bleeding 1

Pharmacologic Adjuncts

  • Proton pump inhibitors can be prescribed to reduce the risk of bleeding from gastric ulcers; however, there are no definitive data supporting their use at this time 1

Admission and Monitoring

  • Patients with severe illness or ongoing instability should be admitted to a high-dependency unit or ICU 2
  • Stable patients can be placed on an acute general medical ward staffed by clinicians experienced in emergency gastrointestinal care 2
  • All care areas must provide round-the-clock expertise, including the capability to perform emergency endoscopy 2

Critical Pitfalls to Avoid

  • Do not delay endoscopy to obtain stool studies; melena is a clinical diagnosis based on visual inspection and digital rectal examination that warrants immediate evaluation 2
  • Do not assume all melena originates from the upper GI tract in obscure cases; while rare, melena can occasionally result from proximal small bowel bleeding beyond the ligament of Treitz, particularly in patients with obscure GI bleeding 4
  • Mortality in GI bleeding relates more to comorbidities than exsanguination; aggressive management of underlying conditions (cardiac, renal, hepatic disease) is essential 1, 2
  • Never perform endoscopy before achieving hemodynamic stability in severely unstable patients; resuscitation must precede diagnostic procedures 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Blood in Stool for 3 Days

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Gastrointestinal Bleeding with Melena and Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the diagnostic steps for melena?
What are the causes of dark tar‑colored stools (melena)?
Is small intestine evaluation necessary for a patient with a history of melena (black, tarry stools), 4 years prior, and normal colonoscopy and esophagogastroduodenoscopy (EGD), with no recurrence since then?
What is the appropriate evaluation and management of a young female adult presenting with hematochezia (blood in stools)?
What is the difference between melena, hematemeza (hematemesis), hematochezia, and rectal bleeding (rectorragie) in terms of gastrointestinal bleeding?
Patient taking insulin glargine (Lantus) 24 units in the morning and metformin/glibenclamide (Galvumet) at 6 pm has pre‑dinner hyperglycemia; what is the next step?
What is the diagnosis and AJCC stage for a 3‑cm right lower‑lobe non‑small‑cell lung carcinoma that is TTF‑1 positive, with malignant involvement of mediastinal nodes stations 4R and 7 (N2) and hilar node 11R (N1), MET immunostain 50% positive, and PD‑L1 0%?
Can volume depletion (dehydration) cause secondary (reactive) thrombocytosis?
In primary hypertension, is amlodipine preferred over cilnidipine as first‑line therapy, and what are the indications for choosing one over the other?
What are the differential diagnoses for pancytopenia in a 46‑year‑old woman with chronic liver disease and portal hypertension?
In an elderly woman with stage IIIA (T2a N2 M0) non‑small cell lung cancer involving mediastinal stations 4R and 7, does her age change the recommended treatment plan, and how would comprehensive molecular profiling (including MET exon 14‑skipping, EGFR, ALK, ROS1, BRAF V600E, KRAS G12C, RET, NTRK) influence management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.